The expression of ANGPT2, GLDN, and ZNF532 was significantly higher in the 268 HCC tumor tissues of the GSE25097 dataset compared to the 243 non-tumor liver tissue samples (p < 0.001; Figure 6K–6M). The gene discussed is GLDN; the disease is hepatocellular carcinoma.